Name | Trastuzumab beta |
---|
Description | Trastuzumab beta (ABP 980) is a biosimilar to Trastuzumab (HY-P9907). Trastuzumab beta is a monoclonal antibody (McAb) targeting human epidermal growth factor receptor 2 (HER2). Trastuzumab beta can be used for the research of HER2-positive metastatic breast cancer, early breast cancer (EBC), and metastatic gastric cancer[1]. |
---|---|
Related Catalog | |
Target |
HER2 |
References |
No Any Chemical & Physical Properties |